Abstract
One in five Americans will develop skin cancer in their lifetime, and while conventional treatments are highly effective, many patients seek complementary therapies. While some of these approaches are dangerous and should be avoided, others hold promise as adjunctive therapy or perhaps in situations where conventional treatments are not possible or desired.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Adler B, Freidman A. Closing a gap in clinical knowledge: analysis of cases of self-treatment of moles and skin cancer with escharotic and nonescharotic agents in the Internet age. Poster Abstract. JAAD. 2014;70(5 (Suppl 1)):AB133.
American Cancer Society cancer facts & figures. 2013. http://cancer.org/acs/group/content/@epidemiologysurveilance/document036845.pdf
Asgari MM, Maruti SS, Kushi LH, White E. A cohort study of vitamin D intake and melanoma risk. J Inves Dermatol. 2009;129(7):1675–80.
Berwick M, Erdei EO. Vitamin D and melanoma incidence and mortality. Pigment Cell Melanoma Res. 2013;26(1):9–15.
Bhaskaran S. Gossypin as a novel selective dual inhibitor of V-RAF murine sarcoma viral oncogene homolog B1 and cyclin-dependent kinase 4 for melanoma. Mol Cancer Ther. 2013;12(4):361–72.
Cham BE, Daunter B, Evans RA. Topical treatment of malignant and premalignant skin lesions by very low concentrations of a standard mixture (BEC) of solasodine glycosides. Cancer Lett. 1991;59(3):183–92.
Cienki JJ, Zaret L. An internet misadventure: bloodroot salve toxicity. J Altern Complement Med. 2010;16(10):1125–7. doi:10.1089/acm.2010.0140. Epub 2010 Oct 9.
Clark CM, Furniss M, Mackay-Wiggan JM. Basal cell cancer: an evidence based treatment update. Am J Clin Dermatol. 2014;15:197–216.
Eastman KL, McFarland LV, Raugi GJ. Buyer beware: a black save caution. JAAD. 2011;65:e154–5.
Elston DM. Escharotic agents, Fred Mohs, and Harry Hoxsey: a commentary. JAAD. 2005;53:523–5.
Fox MC, Lao CD, Schwartz JL, Frohm ML, Bichakjian CK, Johnson TM. Management options for metastatic melanoma in the era of novel therapies: a primer for the practicing dermatologist. Part II. Management of Stage IV Disease. JAAD. 2013;68(1):13e.1–13.
http://www.antiaging-systems.com/23-bec5-curaderm?Aff=WRC1. Accessed 26 May 2014.
Javed S, Tyring SK. Treatment of molluscum contagiosum with ingenol mebutate. J Am Acad Dermatol. 2014;70(5):e105.
Jellinek N, Maloney ME. Escharotic and other botanical agents for the treatment of skin cancer: a review. JAAD. 2005;53:487–95.
Leonard GH, Landau JM, Moody MN, Vergilis-Kalner IJ. Treatment of Bowen’s disease on the penis with low concentration of standard mixture of solasodine glycosides and liquid nitrogen. Dermatol Surg. 2011;37:858–61.
Marks R, Rennie G, Selwood RS. Malignant transformation of solar keratoses to squamous cell carcinoma. Lancet. 1988;1(8589):796–7.
McDaniel S, Goldman GD. Consequences of using escharotic agents as primary treatment for nonmelanoma skin cancer. Arch Dermatol. 2002;138:1593–6.
Mostterd K, Krekels GA, Nieman FH, et al. Surgical excision v Mohs micrographic surgery for primary and recurrent basal cell cancer if the face; a prospective randomized controlled trial with 5-years follow-up. Lancet Oncol. 2008;9(12):1149–56.
Newton-Bishop JA, et al. Serum 25-hydroxyvitaminD3 levels are associated with breslow thickness at presentation and survival form melanoma. J Clin Oncol. 2009;27(32):5439–44.
Nurnberg B, et al. Reduced serum 25-hydroxyvitamin D levels in stage IV melanoma patients. Anticancer Res. 2009;29(9):3669–74.
Rogers H. Your new study of non melanoma skin cancers. New York: Skin Cancer Foundation, Skin Cancer.org; 2010.
Rosen RH, Gupta AK, Tyring SK. Dual mechanism of action of Ingenol mebutate gel for the topical treatment of actinic keratosis: rapid necrosis followed by specific immune response. JAAD. 2012;66(3):486–693.
Rusciani L, Proietti I, Rusciani A, Paradisi A, Sbordoni G, Alfano C, Panunzi S, De Gaetano A, Lippa S. Low plasma coenzyme Q10 levels as an independent prognostic factor for melanoma progression. J Am Acad Dermatol. 2006;54(2):234–41.
Smith N, Shin DB, Brauer JA, Mao J, Glefand JM. Use of complementary and alternative medicine among adults with skin disease: results from a national survey. JAAD. 2010;60(3):419–25.
Sun Protection. Cancer trends progress report—2009/2010 update. National Cancer Institute. http://progressreport.cancer.gov. Accessed 26 Jan 2015.
Uhlenake EE. Optimal treatment of Actinic keratoses. Clin Interv Aging. 2013;8:29–35.
Weinstock MA, Stampfer MJ, Lew RA, Willett WC, Sober AJ. Case control study of melanoma and dietary vitamin D: implications for advocacy of sun protection and sunscreen use. J Invest Dermatol. 1992;98(5):809–11.
Author information
Authors and Affiliations
Rights and permissions
Copyright information
© 2015 Springer International Publishing Switzerland
About this chapter
Cite this chapter
Lio, P.A., Patel, T., Peters, N.T., Kasprowicz, S. (2015). Skin Cancer. In: Handbook of Integrative Dermatology. Springer, Cham. https://doi.org/10.1007/978-3-319-17816-5_4
Download citation
DOI: https://doi.org/10.1007/978-3-319-17816-5_4
Publisher Name: Springer, Cham
Print ISBN: 978-3-319-17815-8
Online ISBN: 978-3-319-17816-5
eBook Packages: MedicineMedicine (R0)